by admin | May 12, 2022 | News
SonoMotion initiates First-In-Human clinical trial of its Break Wave™ stone fragmentation system.
by admin | May 12, 2022 | News
SonoMotion secures a $3M SBIR Phase IIB grant from the NIH in support of its Break Wave™ First-In-Human clinical trial. Planned sites include UW, UBC, UCSD, Cleveland Clinic and Chesapeake Urology.
by admin | May 12, 2022 | News
GE Healthcare and SonoMotion sign a second co-development agreement and expand their strategic relationship with an updated OEM agreement.
by admin | May 12, 2022 | News
SonoMotion receives Health Canada ITA approval to initiate its Break Wave™ First-In-Human clinical trial in Canada.
by admin | May 12, 2022 | News
SonoMotion receives FDA IDE approval to initiate its Break Wave™ First-In-Human clinical trial in the United States.
by admin | May 12, 2022 | News
GE Healthcare and SonoMotion establish a strategic partnership and sign a definitive OEM agreement and co-development agreement.
Recent Comments